Ropes & Gray LLP has advised Tanabe Pharma Corporation in its agreement with LEO Pharma. Tanabe Pharma Corporation has announced the transfer of all global development...
Tanabe Pharma Sells Global Rights to Oral Therapy Dersimelagon to LEO Pharma
Novanta Acquires Riverpoint Medical for Up to $1.45 Billion
Ropes & Gray has advised Novanta. Novanta Inc. (NASDAQ: NOVT) has entered into a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for an...
LPL Financial’s $2.7 Billion Acquisition of Commonwealth Financial Network
Ropes & Gray advised Commonwealth Financial Network on the transaction, and Allen Overy Shearman Sterling US advised LPL Holdings, Inc. LPL Financial Holdings Inc. (NASDAQ: LPLA)...
Paramount’s $28 Billion Merger Agreement with Skydance
Latham & Watkins and Beccar Varela advised Skydance and the Investor Group on the transaction; Sullivan & Cromwell advised RedBird Capital Partners; Ropes & Gray advised...
Pfizer’s Acquisition of Biohaven Pharmaceutical
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
Medtronic’s $1 Billion Acquisition of Intersect ENT
Cooley advised Intersect ENT on the deal, while Ropes & Gray advised Medtronic. Intersect ENT, a global ear, nose and throat medical technology leader dedicated to...